PAVmed Balance Sheet Health
Financial Health criteria checks 3/6
PAVmed has a total shareholder equity of $40.9M and total debt of $6.6M, which brings its debt-to-equity ratio to 16.1%. Its total assets and total liabilities are $52.8M and $11.9M respectively.
Key information
16.12%
Debt to equity ratio
US$6.60m
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.70m |
| Equity | US$40.93m |
| Total liabilities | US$11.89m |
| Total assets | US$52.82m |
Recent financial health updates
Recent updates
Veris Health's NIH Grant May Boost Future Revenue, But Financing Uncertainty Could Persist
Strategic restructuring and subsidiary deconsolidation aim to strengthen the financial structure and improve net margins.Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%?
Jan 29
Is PAVmed (NASDAQ:PAVM) Using Debt In A Risky Way?
Aug 17PAVmed Non-GAAP EPS of -$0.17 beats by $0.03
Aug 16PAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term Progress
Jul 05Start Accumulating PAVmed
Dec 24We Think PAVmed (NASDAQ:PAVM) Can Afford To Drive Business Growth
Sep 02PAVmed: Long Term Investment Case Remains Despite Weak Q2
Aug 23PAVmed (NASDAQ:PAVM) Is In A Good Position To Deliver On Growth Plans
May 19Do Institutions Own PAVmed Inc. (NASDAQ:PAVM) Shares?
Dec 16Financial Position Analysis
Short Term Liabilities: PAVM's short term assets ($3.6M) do not cover its short term liabilities ($9.8M).
Long Term Liabilities: PAVM's short term assets ($3.6M) exceed its long term liabilities ($2.1M).
Debt to Equity History and Analysis
Debt Level: PAVM's net debt to equity ratio (9.5%) is considered satisfactory.
Reducing Debt: PAVM had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: PAVM's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if PAVM's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 23:01 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PAVmed Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Raymond Myers | Benchmark Company |
| Anthony Vendetti | Maxim Group |